To Order: patrick@cotinis.com
VHL Polyclonal Antibody |
|||
46866-100ul | SAB | 100ul | EUR 302.4 |
VHL Polyclonal Antibody |
|||
46866-50ul | SAB | 50ul | EUR 224.4 |
VHL Polyclonal Antibody |
|||
ABP56500-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68 |
VHL Polyclonal Antibody |
|||
ABP56500-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68 |
VHL Polyclonal Antibody |
|||
ABP56500-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68 |
VHL Polyclonal Antibody |
|||
ABP60891-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50 |
VHL Polyclonal Antibody |
|||
ABP60891-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50 |
VHL Polyclonal Antibody |
|||
ABP60891-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50 |
VHL Rabbit pAb |
|||
A11240-100ul | Abclonal | 100 ul | EUR 369.6 |
VHL Rabbit pAb |
|||
A11240-200ul | Abclonal | 200 ul | EUR 550.8 |
VHL Rabbit pAb |
|||
A11240-20ul | Abclonal | 20 ul | EUR 219.6 |
VHL Rabbit pAb |
|||
A11240-50ul | Abclonal | 50 ul | EUR 267.6 |
VHL Rabbit pAb |
|||
A16287-100ul | Abclonal | 100 ul | EUR 369.6 |
VHL Rabbit pAb |
|||
A16287-200ul | Abclonal | 200 ul | EUR 550.8 |
VHL Rabbit pAb |
|||
A16287-20ul | Abclonal | 20 ul | EUR 219.6 |
VHL Rabbit pAb |
|||
A16287-50ul | Abclonal | 50 ul | EUR 267.6 |
VHL Rabbit pAb |
|||
A0377-100ul | Abclonal | 100 ul | EUR 369.6 |
VHL Rabbit pAb |
|||
A0377-200ul | Abclonal | 200 ul | EUR 550.8 |
VHL Rabbit pAb |
|||
A0377-20ul | Abclonal | 20 ul | EUR 219.6 |
VHL Rabbit pAb |
|||
A0377-50ul | Abclonal | 50 ul | EUR 267.6 |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
DLR-vHL-Hu-48T | DL Develop | 48T | EUR 658.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Von Hippel Lindau Tumor Suppressor (vHL) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
DLR-vHL-Hu-96T | DL Develop | 96T | EUR 861.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Von Hippel Lindau Tumor Suppressor (vHL) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
DLR-vHL-Ra-48T | DL Develop | 48T | EUR 658.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Von Hippel Lindau Tumor Suppressor (vHL) in samples from tissue homogenates or other biological fluids. |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
DLR-vHL-Ra-96T | DL Develop | 96T | EUR 861.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Rat Von Hippel Lindau Tumor Suppressor (vHL) in samples from tissue homogenates or other biological fluids. |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RD-vHL-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 668.4 |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RD-vHL-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 930 |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RD-vHL-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 668.4 |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RD-vHL-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 930 |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RDR-vHL-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 699.6 |
Human Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RDR-vHL-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 973.2 |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RDR-vHL-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 699.6 |
Rat Von Hippel Lindau Tumor Suppressor (vHL) ELISA Kit |
|||
RDR-vHL-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 973.2 |
VHL Antibody |
|||
1-CSB-PA071125 | Cusabio |
|
|
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
VHL Antibody |
|||
1-CSB-PA060067 | Cusabio |
|
|
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
VHL Antibody |
|||
1-CSB-PA991849 | Cusabio |
|
|
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:50-1:200 |
VHL Antibody |
|||
DF6104 | Affbiotech | 200ul | EUR 420 |
VHL Antibody |
|||
AF6292 | Affbiotech | 200ul | EUR 420 |
VHL Antibody |
|||
1-CSB-PA876839 | Cusabio |
|
|
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000 |
VHL Antibody |
|||
CSB-PA025852KA01HU-100ul | Cusabio | 100ul | EUR 466.8 |
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
VHL antibody |
|||
70R-34605 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Purified Rabbit polyclonal VHL antibody |
VHL antibody |
|||
70R-9757 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Affinity purified rabbit polyclonal VHL antibody |
VHL Antibody |
|||
32075-100ul | SAB | 100ul | EUR 302.4 |
VHL antibody |
|||
10R-1029 | Fitzgerald | 100 ul | EUR 379.2 |
Description: Mouse monoclonal VHL antibody |
VHL Antibody |
|||
ABF6292 | Lifescience Market | 100 ug | EUR 525.6 |
VHL Antibody |
|||
ABD6104 | Lifescience Market | 100 ug | EUR 525.6 |
VHL Antibody |
|||
R35773-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
VHL Antibody |
|||
CSB-PA025852KA01HU- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
VHL Antibody |
|||
F49681-0.05ML | NSJ Bioreagents | 0.05 ml | EUR 165 |
VHL Antibody |
|||
F49681-0.2ML | NSJ Bioreagents | 0.2 ml | EUR 379 |
VHL Antibody |
|||
F49682-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
VHL Antibody |
|||
F49682-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 389 |
VHL (phospho Ser68) Polyclonal Antibody |
|||
ES7498-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA |
VHL (phospho Ser68) Polyclonal Antibody |
|||
ES7498-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA |
VHL (phospho Ser68) Polyclonal Antibody |
|||
ABP56499-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68 |
VHL (phospho Ser68) Polyclonal Antibody |
|||
ABP56499-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68 |
VHL (phospho Ser68) Polyclonal Antibody |
|||
ABP56499-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68 |
Polyclonal VHL Antibody (C-term) |
|||
APR10723G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VHL (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal Goat Anti-VHL Antibody |
|||
AMM05157G | Leading Biology | 0.1 mg | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-VHL . This antibody is tested and proven to work in the following applications: |
VHL/ Rat VHL ELISA Kit |
|||
ELA-E1894r | Lifescience Market | 96 Tests | EUR 1063.2 |
Vhl/ Rat Vhl ELISA Kit |
|||
ELI-06080r | Lifescience Market | 96 Tests | EUR 1063.2 |
VHL Conjugated Antibody |
|||
C32075 | SAB | 100ul | EUR 476.4 |
Human VHL Antibody |
|||
32825-05111 | AssayPro | 150 ug | EUR 313.2 |
VHL (pS68) Antibody |
|||
abx219320-100ug | Abbexa | 100 ug | EUR 526.8 |
anti- VHL antibody |
|||
FNab09402 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against VHL |
anti- VHL antibody |
|||
FNab10175 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against VHL |
Anti-VHL antibody |
|||
PAab09402 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-VHL antibody |
|||
STJ113440 | St John's Laboratory | 50 µl | EUR 332.4 |
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. |
Anti-VHL antibody |
|||
STJ113742 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. |
Anti-VHL antibody |
|||
STJ26089 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. |
Anti-VHL Antibody |
|||
STJ502735 | St John's Laboratory | 100 µg | EUR 571.2 |
Anti-VHL antibody |
|||
STJ70964 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-VHL antibody |
|||
STJ118733 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-VHL antibody |
|||
STJ96241 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to VHL. |
Anti-VHL antibody |
|||
STJ98809 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to VHL. |
VHL (Phospho-Ser68) Polyclonal Conjugated Antibody |
|||
C12654 | SAB | 100ul | EUR 476.4 |
VHL siRNA |
|||
20-abx939411 | Abbexa |
|
|
VHL siRNA |
|||
20-abx939412 | Abbexa |
|
|
VHL Peptide |
|||
45-170P | ProSci | 0.1 mg | EUR 405.6 |
Description: (IN) VHL Peptide |
VHL siRNA |
|||
20-abx906024 | Abbexa |
|
|
Phospho-VHL (S68) Antibody |
|||
1-CSB-PA060066 | Cusabio |
|
|
Description: A polyclonal antibody against Phospho-VHL (S68). Recognizes Phospho-VHL (S68) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000 |
Phospho-VHL (Ser68) Antibody |
|||
AF8334 | Affbiotech | 200ul | EUR 540 |
VHL (Phospho-Ser68) Antibody |
|||
12654-100ul | SAB | 100ul | EUR 302.4 |
VHL (Phospho-Ser68) Antibody |
|||
12654-50ul | SAB | 50ul | EUR 224.4 |
VHL (Phospho- Ser68) Antibody |
|||
ABF8334 | Lifescience Market | 100 ug | EUR 525.6 |
Anti-VHL Antibody (Biotin) |
|||
STJ502736 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-VHL Antibody (FITC) |
|||
STJ502737 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-VHL, Biotinylated antibody |
|||
STJ73173 | St John's Laboratory | 100 µg | EUR 430.8 |
Polyclonal VHL / Von Hippel Lindau Antibody (aa34-83) |
|||
APR10721G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VHL / Von Hippel Lindau (aa34-83). This antibody is tested and proven to work in the following applications: |
VHL Blocking Peptide |
|||
DF6104-BP | Affbiotech | 1mg | EUR 234 |
VHL Blocking Peptide |
|||
AF6292-BP | Affbiotech | 1mg | EUR 234 |
VHL cloning plasmid |
|||
CSB-CL025852HU-10ug | Cusabio | 10ug | EUR 306 |
Description: A cloning plasmid for the VHL gene. |
VHL Mouse mAb |
|||
A11872-100ul | Abclonal | 100 ul | Ask for price |
VHL Mouse mAb |
|||
A11872-200ul | Abclonal | 200 ul | Ask for price |
VHL Mouse mAb |
|||
A11872-20ul | Abclonal | 20 ul | Ask for price |
VHL Mouse mAb |
|||
A11872-50ul | Abclonal | 50 ul | EUR 318 |
VHL Blocking Peptide |
|||
33R-2312 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of VHL antibody, catalog no. 70R-9757 |
Recombinant human VHL |
|||
P2120 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human VHL |
Human VHL Antibody (Biotin Conjugate) |
|||
32825-05121 | AssayPro | 150 ug | EUR 442.8 |
Anti-Phospho-VHL (S68) antibody |
|||
STJ91273 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to Phospho-VHL (S68). |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat) |
|||
4-PAJ769Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL) |
Rat VHL shRNA Plasmid |
|||
20-abx984685 | Abbexa |
|
|
Human VHL shRNA Plasmid |
|||
20-abx955082 | Abbexa |
|
|
Mouse VHL shRNA Plasmid |
|||
20-abx973364 | Abbexa |
|
|
Human VHL ELISA Kit |
|||
ELA-E1894h | Lifescience Market | 96 Tests | EUR 988.8 |
Canine VHL ELISA KIT |
|||
ELI-06083d | Lifescience Market | 96 Tests | EUR 1113.6 |
VHL ELISA KIT|Human |
|||
EF006088 | Lifescience Market | 96 Tests | EUR 826.8 |
pCMV-HA-VHL Plasmid |
|||
PVTB00168-2a | Lifescience Market | 2 ug | EUR 427.2 |
VHL Recombinant Protein (Human) |
|||
RP034324 | ABM | 100 ug | Ask for price |
VHL Recombinant Protein (Mouse) |
|||
RP183791 | ABM | 100 ug | Ask for price |
VHL Recombinant Protein (Rat) |
|||
RP236390 | ABM | 100 ug | Ask for price |
ELOB/ELOC/VHL Complex |
|||
100361-1 | BPS Bioscience | 10 µg | EUR 210 |
Description: ELOB/ELOC/VHL complex of human ELOB (GenBank Accession No. NM_007108), a.a. 2-118 with N-terminal FLAG-tag and MW= 14 kDa; ELOC (GenBank Accession No. NM_005648), a.a. 2-86 with N-terminal His-tag and MW= 13; human VHL (GenBank Accession No. NM_000551) a.a. 2-212(end) with N-terminal FLAG-tag and MW= 25 kDa, individually expressed in a HEK293 expression system. |
ELOB/ELOC/VHL Complex |
|||
100361-2 | BPS Bioscience | 50 µg | EUR 535 |
Description: ELOB/ELOC/VHL complex of human ELOB (GenBank Accession No. NM_007108), a.a. 2-118 with N-terminal FLAG-tag and MW= 14 kDa; ELOC (GenBank Accession No. NM_005648), a.a. 2-86 with N-terminal His-tag and MW= 13; human VHL (GenBank Accession No. NM_000551) a.a. 2-212(end) with N-terminal FLAG-tag and MW= 25 kDa, individually expressed in a HEK293 expression system. |
Human VHL AssayLite Antibody (FITC Conjugate) |
|||
32825-05141 | AssayPro | 150 ug | EUR 513.6 |
Human VHL AssayLite Antibody (RPE Conjugate) |
|||
32825-05151 | AssayPro | 150 ug | EUR 513.6 |
Human VHL AssayLite Antibody (APC Conjugate) |
|||
32825-05161 | AssayPro | 150 ug | EUR 513.6 |
Human VHL AssayLite Antibody (PerCP Conjugate) |
|||
32825-05171 | AssayPro | 150 ug | EUR 565.2 |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), APC |
|||
4-PAJ769Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with APC. |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), Biotinylated |
|||
4-PAJ769Ra01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with Biotin. |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAJ769Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with Cy3. |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), FITC |
|||
4-PAJ769Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with FITC. |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), HRP |
|||
4-PAJ769Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with HRP. |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), PE |
|||
4-PAJ769Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with PE. |
Von Hippel Lindau Tumor Suppressor (vHL) Antibody |
|||
20-abx175113 | Abbexa |
|
|
Von Hippel Lindau Tumor Suppressor (vHL) Antibody |
|||
20-abx131162 | Abbexa |
|
|
Von Hippel Lindau Tumor Suppressor (VHL) Antibody |
|||
20-abx210322 | Abbexa |
|
|
Von Hippel Lindau Tumor Suppressor (VHL) Antibody |
|||
20-abx211119 | Abbexa |
|
|
Von Hippel Lindau Tumor Suppressor (VHL) Antibody |
|||
20-abx323201 | Abbexa |
|
|
Von Hippel Lindau Tumor Suppressor (VHL) Antibody |
|||
20-abx326550 | Abbexa |
|
|
Monoclonal VHL Antibody (monoclonal) (M01), Clone: 1G12 |
|||
APR10724G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A Monoclonal antibody against Human VHL (monoclonal) (M01). The antibodies are raised in mouse and are from clone 1G12. This antibody is applicable in WB and IF, E |
Von Hippel Lindau Tumor Suppressor (vHL) Polyclonal Antibody (Rat), APC-Cy7 |
|||
4-PAJ769Ra01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Von Hippel Lindau Tumor Suppressor (vHL). This antibody is labeled with APC-Cy7. |
Phospho-VHL (Ser68) Blocking Peptide |
|||
AF8334-BP | Affbiotech | 1mg | EUR 234 |
VHL ELISA Kit (Rat) (OKCD02977) |
|||
OKCD02977 | Aviva Systems Biology | 96 Wells | EUR 1075.2 |
Description: Description of target: Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2. <p>This subsection of the <a href="//www.uniprot.org/help/function_section">‘Function’</a> section describes the metabolic pathway(s) associated with a protein.<p><a href='/help/pathway' target='_top'>More...</a></p>Pathwayi: protein ubiquitinationThis protein is involved in the pathway protein ubiquitination, which is part of Protein modification._x000D_View all proteins of this organism that are known to be involved in the pathway protein ubiquitination and in Protein modification. ;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.113 ng/mL |
VHL ELISA Kit (Mouse) (OKEH05306) |
|||
OKEH05306 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2. This subsection of the ‘Function’ section describes the metabolic pathway(s) associated with a protein. More..;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.086 ng/mL |
Vhl ORF Vector (Rat) (pORF) |
|||
ORF078798 | ABM | 1.0 ug DNA | EUR 607.2 |
Vhl ORF Vector (Mouse) (pORF) |
|||
ORF061265 | ABM | 1.0 ug DNA | EUR 607.2 |
VHL ELISA Kit (Rat) (OKEH07205) |
|||
OKEH07205 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2.;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.087 ng/mL |
VHL ORF Vector (Human) (pORF) |
|||
ORF011442 | ABM | 1.0 ug DNA | EUR 114 |
Mouse Anti-Human VHL monoclonal antibody, clone JID794 |
|||
CABT-L2880-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | EUR 602.4 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx125410-50ul | Abbexa | 50 ul | EUR 427.2 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
20-abx137392 | Abbexa |
|
|
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx117007-100ug | Abbexa | 100 ug | EUR 560.4 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
20-abx126781 | Abbexa |
|
|
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
20-abx000699 | Abbexa |
|
|
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx012353-100ug | Abbexa | 100 ug | EUR 526.8 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx032864-400ul | Abbexa | 400 ul | EUR 627.6 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx032864-80l | Abbexa | 80 µl | EUR 343.2 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx032865-400ul | Abbexa | 400 ul | EUR 627.6 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx032865-80l | Abbexa | 80 µl | EUR 343.2 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx431703-200ul | Abbexa | 200 ul | EUR 460.8 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx239402-100ug | Abbexa | 100 ug | EUR 610.8 |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody |
|||
abx219331-100ug | Abbexa | 100 ug | EUR 526.8 |
VHL protein, betadomain protein (His tag) |
|||
80R-1008 | Fitzgerald | 100 ug | EUR 268.8 |
Description: Purified recombinant Human VHL protein, betadomain protein |
VHL sgRNA CRISPR Lentivector set (Human) |
|||
K2611301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Vhl sgRNA CRISPR Lentivector set (Mouse) |
|||
K4414101 | ABM | 3 x 1.0 ug | EUR 406.8 |
Vhl sgRNA CRISPR Lentivector set (Rat) |
|||
K6798701 | ABM | 3 x 1.0 ug | EUR 406.8 |
VHL intrachain TR-FRET Assay Kit |
|||
78305 | BPS Bioscience | 384 rxns. | EUR 1550 |
Description: Covalent conjugation to ubiquitin (Ub) is one of the major post-translational modifications that regulates protein stability, function, and localization. Ubiquitination is the concerted action of three enzymes: a Ub-activating enzyme (E1), a Ub-conjugating enzyme (E2), and a Ub ligase (E3). The specificity and efficiency of ubiquitination are largely determined by the E3 enzyme, which directs the last step of the Ub-conjugating cascade by binding to both an E2~Ub conjugate and a substrate protein. This step ensures the transfer of Ub from E2~Ub to the substrate, leading to its mono- or poly-ubiquitination.The von Hippel-Lindau protein (VHL) interacts with Elongins B and C, Cullin 2, and Ring Box Protein 1 (Rbx1) to form the functional E3 Ub ligase complex where it functions as a substrate recognition entity. Most of the tumor-derived mutations within VHL disrupt its tumor suppressor role by compromising its substrate receptor function and generally whole VHL complex Ub ligase activity. VHL complex not only targets the alpha subunits of the heterodimeric transcription factor hypoxia inducible factor (HIF) for ubiquitylation and proteasomal degradation, but it is involved in many other biological processes related to tumor growth. That is why it is an attractive potential drug target in cancer immunotherapy. Like most E3 ligases, VHL complex can ubiquitinate itself.The VHL intrachain TR-FRET Assay Kit is a sensitive high-throughput screening (HTS) TR-FRET Assay Kit, designed to measure VHL auto-ubiquitination activity in a homogeneous 384 reaction format. It utilizes a Europium cryptate-labeled Ub (donor) as well as Cy5-labeled Ub (acceptor) to complete the TR-FRET pairing. Since both the TR-FRET donor and acceptor are incorporated into poly-ubiquitin chains formed on VHL, this FRET-based assay requires no time-consuming washing steps, making it especially suitable for HTS applications as well as real-time kinetics analyses of polyubiquitination. |
VHL/CUL2/ELOB/ELOC/RBX1 Complex |
|||
100373-1 | BPS Bioscience | 10 µg | EUR 215 |
Description: VHL/CUL2/ELOB/ELOC/RBX1 complex of human VHL (GenBank Accession No. NM_000551) a.a. 2-212(end) with N-terminal FLAG-tag and MW= 25 kDa, human CUL2 (GenBank Accession No. NM_003591), a.a. 2-745(end) with N-terminal FLAG-tag and MW= 88 kDa, human ELOB (GenBank Accession No. NM_007108), a.a. 2-118 with N-terminal FLAG-tag and MW= 14 kDa, ELOC (GenBank Accession No. NM_005648), a.a. 2-112(end) with N-terminal His-tag and MW= 13 kDa human Rbx1 (GenBank Accession No. NM_014248), a.a. 2-108(end) with N-terminal His-tag and MW= 13 kDa, individually expressed in a HEK293 expression system. |
VHL/CUL2/ELOB/ELOC/RBX1 Complex |
|||
100373-2 | BPS Bioscience | 50 µg | EUR 545 |
Description: VHL/CUL2/ELOB/ELOC/RBX1 complex of human VHL (GenBank Accession No. NM_000551) a.a. 2-212(end) with N-terminal FLAG-tag and MW= 25 kDa, human CUL2 (GenBank Accession No. NM_003591), a.a. 2-745(end) with N-terminal FLAG-tag and MW= 88 kDa, human ELOB (GenBank Accession No. NM_007108), a.a. 2-118 with N-terminal FLAG-tag and MW= 14 kDa, ELOC (GenBank Accession No. NM_005648), a.a. 2-112(end) with N-terminal His-tag and MW= 13 kDa human Rbx1 (GenBank Accession No. NM_014248), a.a. 2-108(end) with N-terminal His-tag and MW= 13 kDa, individually expressed in a HEK293 expression system. |
Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody (Biotin) |
|||
abx431704-200ul | Abbexa | 200 ul | EUR 460.8 |
VHL ELISA Kit (Human) : 96 Wells (OKEH01354) |
|||
OKEH01354 | Aviva Systems Biology | 96 Wells | EUR 888 |
Description: Description of target: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. ;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL |
VHL sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2611302 | ABM | 1.0 ug DNA | EUR 184.8 |
VHL sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2611303 | ABM | 1.0 ug DNA | EUR 184.8 |
VHL sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2611304 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4414102 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4414103 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4414104 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6798702 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6798703 | ABM | 1.0 ug DNA | EUR 184.8 |
Vhl sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6798704 | ABM | 1.0 ug DNA | EUR 184.8 |
VHL Protein Vector (Human) (pPB-C-His) |
|||
PV045765 | ABM | 500 ng | EUR 394.8 |
VHL Protein Vector (Human) (pPB-N-His) |
|||
PV045766 | ABM | 500 ng | EUR 394.8 |
VHL Protein Vector (Human) (pPM-C-HA) |
|||
PV045767 | ABM | 500 ng | EUR 394.8 |
VHL Protein Vector (Human) (pPM-C-His) |
|||
PV045768 | ABM | 500 ng | EUR 394.8 |
Recombinant Human VHL Protein, His, E.coli-10ug |
|||
QP13934-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Human VHL Protein, His, E.coli-1mg |
|||
QP13934-1mg | EnQuireBio | 1mg | EUR 2230.8 |
Recombinant Human VHL Protein, His, E.coli-50ug |
|||
QP13934-50ug | EnQuireBio | 50ug | EUR 241.2 |
VHL Protein Vector (Mouse) (pPB-C-His) |
|||
PV245058 | ABM | 500 ng | EUR 723.6 |
VHL Protein Vector (Mouse) (pPB-N-His) |
|||
PV245059 | ABM | 500 ng | EUR 723.6 |
VHL Protein Vector (Mouse) (pPM-C-HA) |
|||
PV245060 | ABM | 500 ng | EUR 723.6 |
VHL Protein Vector (Mouse) (pPM-C-His) |
|||
PV245061 | ABM | 500 ng | EUR 723.6 |